Relationship Between Five GWAS-identified Single Nucleotide Polymorphisms and Female Breast Cancer in the Chinese Han Population

Overview

Journal Tumour Biol

Publisher Sage Publications

Specialty Oncology

Date 2016 Jan 25

PMID 26803517

Citations 5

Authors

Yaning He

Hui Liu

Qi Chen

Xianfu Sun

Chaojun Liu

Yingbo Shao

Affiliations

Soon will be listed here.

Abstract

With the development of genome-wide association study (GWAS), an increasing number of genetic variables have been confirmed to be associated with breast cancer. Furthermore, an increasing number of studies from Asian populations are becoming available. Few GWAS loci have been replicated in the Chinese Han population. In a case-control study of breast cancer in the Henan Tumor Hospital (253 cases/339 controls), we evaluated five SNPs from GWAS of populations of European or Asian ancestry. In order to evaluate the contribution of genetic factors to population differences in breast cancer subtypes, all cases are defined by estrogen (ER), progesterone (PR) receptor, Human epidermal growth factor receptor - 2 (HER2), and Ki67 status. Different genotypes of rs3803662 (TOX3)/ (TNRC9)) in the case group and the control group are statistically significant (P = 0.044), but the ones of rs10069690 (TERT), rs2046210 (6q25.1), rs2981582 (EGFR2), and rs889312 (MAP3K1) have no significant statistical differences with breast cancer (P = 0.772, 0.308, 0.376, 0.468). The allelic frequencies of rs3803662 between the case group and the control group differ in recessive genetic models (odds ratio (OR) = 2.04, 95 % confidence interval (CI) 1.14-3.66) and in con-dominant inheritance models (OR = 2.17, 95 % CI 1.18-4.00). Compared with AA and GA, GG increased the risk of breast cancer (P = 0.017, 0.013). The genotype of rs2046210 (6q25.1), rs2981582 (EGFR2), rs889312 (MAP3K1), and rs3803662 (TOX3/TNRC9) has no statistical differences in different subtypes of breast cancer. Five common breast cancer susceptibility loci from GWAS are not strongly associated with breast cancer risk among the Han Chinese of the Henan province; only rs3803662 (TOX3/TNRC9) is confirmed to increase the risk of breast cancer. The different genotypes of five loci distribute equally in different subtypes of breast cancer.

Citing Articles

Polymorphisms of telomere-length related genes in three China ethnic groups.

Niu F, Li J, Li J, Yan M, Shi X, Jin T Int J Clin Exp Pathol. 2020; 10(9):9654-9665.

PMID: 31966846 PMC: 6965982.

Association between the TOX3 rs3803662 C>T polymorphism and recurrent miscarriage in a southern Chinese population.

Huang W, Zhou H, Li Q, Pi L, Xu Y, Fu L J Clin Lab Anal. 2019; 33(9):e22992.

PMID: 31454102 PMC: 6868414. DOI: 10.1002/jcla.22992.

Relationships between SNPs and prognosis of breast cancer and pathogenic mechanism.

He Y, Liu H, Chen Q, Shao Y, Luo S Mol Genet Genomic Med. 2019; 7(9):e871.

PMID: 31317673 PMC: 6732281. DOI: 10.1002/mgg3.871.

The 6q25.1 rs2046210 polymorphism is associated with an elevated susceptibility to breast cancer: A meta-analysis of 261,703 subjects.

Jin T, Zhang W, Zhou Z Mol Genet Genomic Med. 2019; 7(3):e553.

PMID: 30693664 PMC: 6418377. DOI: 10.1002/mgg3.553.

Association of single nucleotide polymorphism rs3803662 with the risk of breast cancer.

Yang Y, Wang W, Liu G, Yu Y, Liao M Sci Rep. 2016; 6:29008.

PMID: 27350156 PMC: 4924094. DOI: 10.1038/srep29008.

References

Zheng W, Long J, Gao Y, Li C, Zheng Y, Xiang Y . Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet. 2009; 41(3):324-8. PMC: 2754845. DOI: 10.1038/ng.318. View

Hartman M, Suo C, Lim W, Miao H, Teo Y, Chia K . Ability to predict breast cancer in Asian women using a polygenic susceptibility model. Breast Cancer Res Treat. 2010; 127(3):805-12. DOI: 10.1007/s10549-010-1279-z. View

Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, Garber J . Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci U S A. 2008; 105(11):4340-5. PMC: 2393811. DOI: 10.1073/pnas.0800441105. View

Stacey S, Manolescu A, Sulem P, Thorlacius S, Gudjonsson S, Jonsson G . Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2008; 40(6):703-6. DOI: 10.1038/ng.131. View

Dai J, Hu Z, Jiang Y, Shen H, Dong J, Ma H . Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women. Breast Cancer Res. 2012; 14(1):R17. PMC: 3496134. DOI: 10.1186/bcr3101. View

Easton D, Pooley K, Dunning A, Pharoah P, Thompson D, Ballinger D . Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007; 447(7148):1087-93. PMC: 2714974. DOI: 10.1038/nature05887. View

Zheng W, Wen W, Gao Y, Shyr Y, Zheng Y, Long J . Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. J Natl Cancer Inst. 2010; 102(13):972-81. PMC: 2897876. DOI: 10.1093/jnci/djq170. View

Stevens K, Vachon C, Lee A, Slager S, Lesnick T, Olswold C . Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res. 2011; 71(19):6240-9. PMC: 3327299. DOI: 10.1158/0008-5472.CAN-11-1266. View

Wacholder S, Hartge P, Prentice R, Garcia-Closas M, Feigelson H, Diver W . Performance of common genetic variants in breast-cancer risk models. N Engl J Med. 2010; 362(11):986-93. PMC: 2921181. DOI: 10.1056/NEJMoa0907727. View

10.

Pharoah P, Antoniou A, Easton D, Ponder B . Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med. 2008; 358(26):2796-803. DOI: 10.1056/NEJMsa0708739. View

11.

Mulligan A, Couch F, Barrowdale D, Domchek S, Eccles D, Nevanlinna H . Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res. 2011; 13(6):R110. PMC: 3326552. DOI: 10.1186/bcr3052. View

12.

Gail M, Mai P . Comparing breast cancer risk assessment models. J Natl Cancer Inst. 2010; 102(10):665-8. DOI: 10.1093/jnci/djq141. View

13.

Stacey S, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson S . Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2007; 39(7):865-9. DOI: 10.1038/ng2064. View

14.

John E, Hopper J, Beck J, Knight J, Neuhausen S, Senie R . The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res. 2004; 6(4):R375-89. PMC: 468645. DOI: 10.1186/bcr801. View

15.

Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, Richesson D . Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet. 2008; 4(4):e1000054. PMC: 2291027. DOI: 10.1371/journal.pgen.1000054. View

16.

Gudmundsdottir E, Barkardottir R, Arason A, Gunnarsson H, Amundadottir L, Agnarsson B . The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients. BMC Cancer. 2012; 12:621. PMC: 3553017. DOI: 10.1186/1471-2407-12-621. View

17.

Hein R, Maranian M, Hopper J, Kapuscinski M, Southey M, Park D . Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One. 2012; 7(8):e42380. PMC: 3413660. DOI: 10.1371/journal.pone.0042380. View

18.

Gail M . Personalized estimates of breast cancer risk in clinical practice and public health. Stat Med. 2011; 30(10):1090-104. PMC: 3079423. DOI: 10.1002/sim.4187. View

19.

Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu L . The incidences and mortalities of major cancers in China, 2009. Chin J Cancer. 2013; 32(3):106-12. PMC: 3845591. DOI: 10.5732/cjc.013.10018. View

20.

Han W, Woo J, Yu J, Lee M, Moon H, Kang D . Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype. Cancer Epidemiol Biomarkers Prev. 2011; 20(5):793-8. DOI: 10.1158/1055-9965.EPI-10-1282. View